Leslie M. Randall, MD, MAS, discusses patient-reported outcomes from the ENGOT-cx11/GOG 3047/KEYNOTE-A18 trial in locally advanced cervical cancer.
Leslie M. Randall, MD, MAS
Advertisement
Articles by Leslie M. Randall, MD, MAS
Leslie M. Randall, MD, MAS, discusses the unmet needs in platinum-resistant ovarian cancer.
Advertisement
Latest Updated Articles
Dr. Randall on Unmet Needs in Platinum-Resistant Ovarian CancerNovember 17th 2020
Advertisement
Advertisement
Trending on OncLive
1
FDA Clears TumorSight Risk, an MRI-Derived AI Recurrence Tool for HR+, HER2– Breast Cancer
2
FDA Approves Dostarlimab for dMMR/MSI-H Locally Advanced Rectal Cancer
3
Vilamakitug Meets OS Threshold in Phase 1/2 Refractory mCRC Trial
4
Dr Cercek on the FDA Approval of Dostarlimab for dMMR/MSI-H Locally Advanced Rectal Cancer
5